Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie F Worth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell Motility and the Cytoskeleton|October 7, 2004
Rho expression and activation in vascular smooth muscle cellsNathalie F Worth, Gordon R Campbell, Julie H Campbell, et al.
Atherosclerosis|June 14, 2005
S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbitsNathalie F Worth, Celia L Berry, Anita C Thomas, et al.
Atherosclerosis|June 29, 2005
Rho and vascular diseaseBarbara E Rolfe, Nathalie F Worth, Cameron J World, et al.
Cardiovascular Research|April 2, 2003
Leukaemia inhibitory factor retards the progression of atherosclerosisBarbara E Rolfe, Steve Stamatiou, Cameron J World, et al.
Journal of Cell Science|January 27, 2005
Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscleQiuping Zhang, Cassandra D Ragnauth, Jeremy N Skepper, et al.
Blood|November 1, 2011
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffoldsLai Y Chan, Sunithi Gunasekera, Sonia T Henriques, et al.
Human Molecular Genetics|September 1, 2007
Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrityQiuping Zhang, Cornelia Bethmann, Nathalie F Worth, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell Motility and the Cytoskeleton|October 7, 2004
Rho expression and activation in vascular smooth muscle cellsNathalie F Worth, Gordon R Campbell, Julie H Campbell, et al.
Atherosclerosis|June 14, 2005
S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbitsNathalie F Worth, Celia L Berry, Anita C Thomas, et al.
Atherosclerosis|June 29, 2005
Rho and vascular diseaseBarbara E Rolfe, Nathalie F Worth, Cameron J World, et al.
Cardiovascular Research|April 2, 2003
Leukaemia inhibitory factor retards the progression of atherosclerosisBarbara E Rolfe, Steve Stamatiou, Cameron J World, et al.
Journal of Cell Science|January 27, 2005
Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscleQiuping Zhang, Cassandra D Ragnauth, Jeremy N Skepper, et al.
Blood|November 1, 2011
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffoldsLai Y Chan, Sunithi Gunasekera, Sonia T Henriques, et al.
Human Molecular Genetics|September 1, 2007
Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrityQiuping Zhang, Cornelia Bethmann, Nathalie F Worth, et al.
Pageof 1